These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6745345)

  • 1. Ascending noradrenergic projections from the brainstem: evidence for a major role in the regulation of blood pressure and vasopressin secretion.
    Lightman SL; Todd K; Everitt BJ
    Exp Brain Res; 1984; 55(1):145-51. PubMed ID: 6745345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascending brain-stem noradrenergic pathways modulate the renin response to haemorrhage.
    Lightman SL; Todd K; Everitt BJ; Brown MJ; Causon RC
    Clin Sci (Lond); 1984 Aug; 67(2):269-72. PubMed ID: 6378492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine-induced catecholamine synthesis after lesions to the dorsal or ventral noradrenergic bundle.
    Mitchell SN; Brazell MP; Schugens MM; Gray JA
    Eur J Pharmacol; 1990 Apr; 179(3):383-91. PubMed ID: 2114296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat.
    Sawchenko PE; Swanson LW
    Brain Res; 1982 Nov; 257(3):275-325. PubMed ID: 6756545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of oxytocin secretion by ascending noradrenergic pathways: sexual dimorphism in rats.
    Carter DA; Lightman SL
    Brain Res; 1987 Mar; 406(1-2):313-6. PubMed ID: 3105813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventral pontine catecholaminergic pathway mediates the vasopressin response to splanchnic osmostimulation in conscious rats.
    King MS; Baertschi AJ
    Brain Res; 1992 May; 580(1-2):81-91. PubMed ID: 1504820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2-adrenergic stimulation within the nucleus tractus solitarius attenuates vasopressin release induced by depletion of cardiovascular volume.
    Iovino M; Vanacore A; Steardo L
    Pharmacol Biochem Behav; 1990 Dec; 37(4):821-4. PubMed ID: 1982697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiology and neuropharmacology of noradrenergic projections to rat PVN magnocellular neurons.
    Saphier D
    Am J Physiol; 1993 May; 264(5 Pt 2):R891-902. PubMed ID: 8388662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological evidence that noradrenergic afferents selectively facilitate the activity of supraoptic vasopressin neurons.
    Day TA; Renaud LP
    Brain Res; 1984 Jun; 303(2):233-40. PubMed ID: 6331571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective mediation of kappa-opioid central cardiovascular effects by ascending noradrenergic pathways.
    Carter DA; Lightman SL
    Exp Brain Res; 1987; 65(3):699-702. PubMed ID: 3556499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholaminergic projections to tuberoinfundibular neurones of the paraventricular nucleus: III. Effects of adrenoceptor agonists and antagonists.
    Saphier D; Feldman S
    Brain Res Bull; 1991 Jun; 26(6):863-70. PubMed ID: 1657318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telencephalic but not diencephalic noradrenaline depletion enhances behavioural but not endocrine measures of fear conditioning to contextual stimuli.
    Selden NR; Everitt BJ; Robbins TW
    Behav Brain Res; 1991 May; 43(2):139-54. PubMed ID: 1867755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal suppression of arginine-vasopressin by clonidine in multiple system atrophy.
    Kimber J; Watson L; Mathias CJ
    Clin Auton Res; 1999 Oct; 9(5):271-4. PubMed ID: 10580879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of neurosecretory vasopressin cells by noradrenergic projections of the caudal ventrolateral medulla.
    Day TA
    Prog Brain Res; 1989; 81():303-17. PubMed ID: 2694223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary nucleus excitation of supraoptic vasopressin cells via adrenergic afferents.
    Day TA; Sibbald JR
    Am J Physiol; 1988 Apr; 254(4 Pt 2):R711-6. PubMed ID: 3128125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus.
    Cunningham ET; Sawchenko PE
    J Comp Neurol; 1988 Aug; 274(1):60-76. PubMed ID: 2458397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of hypothalamic catecholamine depletion on the release of arginine vasopressin and CRF-41 into hypothalamo-hypophyseal portal blood.
    Eckland DJ; Todd K; Jessop DS; Biswas S; Lightman SL
    Neurosci Lett; 1988 Aug; 90(3):292-6. PubMed ID: 3138577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a functional relationship between noradrenaline and neurohypophyseal peptides in the brainstem of rats.
    Vallejo M; Lightman SL
    Brain Res; 1987 Oct; 422(2):295-302. PubMed ID: 3676790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efferent projections from the paraventricular nucleus mediating alpha 2-noradrenergic feeding.
    Weiss GF; Leibowitz SF
    Brain Res; 1985 Nov; 347(2):225-38. PubMed ID: 4063807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of vasopressin synthesis and release by area postrema in rats.
    Arima H; Kondo K; Murase T; Yokoi H; Iwasaki Y; Saito H; Oiso Y
    Endocrinology; 1998 Apr; 139(4):1481-6. PubMed ID: 9528924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.